1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow P-Sam: new trials by email Literature Review of P-Sam trials Research Report on P-Sam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) P-Sam - Adenoid Cystic Carcinoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 28 | 2026-04-29 | 2026-11-02 |
M.D. Anderson Cancer Center (1)
United States (1)